文献速递造血干细胞移植与细胞治疗

载有抗HSP47 siRNA的维生素A偶联脂质体改善慢性移植物抗宿主病皮肤纤维化

Vitamin A-coupled liposomes containing siRNA against HSP47 ameliorate skin fibrosis in chronic graft-versus-host disease.
PubMed 文献 · Blood · 2018-01-23

研究在小鼠同种异体造血干细胞移植后慢性GVHD模型中探索HSP47在皮肤纤维化中的作用,发现维生素A偶联脂质体携带HSP47 siRNA可特异性分布至皮肤纤维化病灶,敲低肌成纤维细胞HSP47并显著减少胶原沉积,且不诱导全身免疫抑制。

要点

  • 同种异体SCT后小鼠皮肤出现大量胶原沉积、F4/80+巨噬细胞及表达HSP47和视黄醇结合蛋白1的肌成纤维细胞积聚。
  • 抗CSF-1受体阻断抗体重复注射显著减少皮肤HSP47+肌成纤维细胞,提示巨噬细胞依赖性积聚。
  • 静脉注射VA-lip HSP47特异性分布于皮肤纤维化病灶,敲低HSP47并显著减少胶原沉积,不诱导全身免疫抑制。

核心结论

  • 慢性GVHD纤维化级联涉及巨噬细胞产生转化生长因子β介导成纤维细胞分化为产生胶原的HSP47+肌成纤维细胞。
  • VA-lip HSP47通过靶向HSP47+肌成纤维细胞而不诱导免疫抑制,代表一种调节慢性GVHD纤维化的新策略。

研究设计与样本

  • 研究为小鼠同种异体造血干细胞移植后慢性GVHD模型的实验研究。

主要发现

  • 免疫组化分析显示同种异体SCT后皮肤大量纤维化,伴胶原沉积增加、F4/80+巨噬细胞积聚以及表达HSP47和视黄醇结合蛋白1的肌成纤维细胞。
  • 重复注射抗CSF-1受体阻断抗体显著减少皮肤HSP47+肌成纤维细胞,表明巨噬细胞依赖性肌成纤维细胞积聚。
  • VA-lip HSP47在体外将HSP47 siRNA递送至表达维生素A受体的细胞并敲低其HSP47。
  • 静脉注射VA-lip HSP47特异性分布于皮肤纤维化病灶,不影响健康皮肤胶原合成。
  • VA-lip HSP47敲低肌成纤维细胞HSP47表达并显著减少胶原沉积,不诱导全身免疫抑制,同时消除唾液腺纤维化。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (SCT) is characterized by multiorgan fibrosis and profoundly affects the quality of life of transplant survivors. Heat shock protein 47 (HSP47), a collagen-specific molecular chaperone, plays a critical role in collagen synthesis in myofibroblasts. We explored the role of HSP47 in the fibrotic process of cutaneous chronic GVHD in mice. Immunohistochemical analysis showed massive fibrosis with elevated amounts of collagen deposits and accumulation of F4/80+ macrophages, as well as myofibroblasts expressing HSP47 and retinol-binding protein 1 in the skin after allogeneic SCT. Repeated injection of anti-colony-stimulating factor (CSF-1) receptor-blocking antibodies significantly reduced HSP47+ myofibroblasts in the skin, indicating a macrophage-dependent accumulation of myofibroblasts. Vitamin A-coupled liposomes carrying HSP47 small interfering RNA (siRNA) (VA-lip HSP47) delivered HSP47 siRNA to cells expressing vitamin A receptors and knocked down their HSP47 in vitro. Intravenously injected VA-lip HSP47 were specifically distributed to skin fibrotic lesions and did not affect collagen synthesis in healthy skin. VA-lip HSP47 knocked down HSP47 expression in myofibroblasts and significantly reduced collagen deposition without inducing systemic immunosuppression. It also abrogated fibrosis in the salivary glands. These results highlight a cascade of fibrosis in chronic GVHD; macrophage production of transforming growth factor β mediates fibroblast differentiation to HSP47+ myofibroblasts that produce collagen. VA-lip HSP47 represent a novel strategy to modulate fibrosis in chronic GVHD by targeting HSP47+ myofibroblasts without inducing immunosuppression.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Yamakawa T, Ohigashi H, Hashimoto D, et al. Vitamin A-coupled liposomes containing siRNA against HSP47 ameliorate skin fibrosis in chronic graft-versus-host disease. Blood. 2018. PMID: 29363541. doi:10.1182/blood-2017-04-779934

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。